The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Arcturus has made progress in cost-cutting and focusing on CF and OTC deficiency. Click here to find out the factors that ...

Sanofi's H5N1 vaccine became the first to be approved by the US FDA back in 2007. Today, ... as best demonstrated by its rapid deployment of effective COVID-19 vaccines.

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1.

The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines ...